BRPI0417046A - métodos para o preparo de aminas estereoisomericamente enriquecidas - Google Patents

métodos para o preparo de aminas estereoisomericamente enriquecidas

Info

Publication number
BRPI0417046A
BRPI0417046A BRPI0417046-6A BRPI0417046A BRPI0417046A BR PI0417046 A BRPI0417046 A BR PI0417046A BR PI0417046 A BRPI0417046 A BR PI0417046A BR PI0417046 A BRPI0417046 A BR PI0417046A
Authority
BR
Brazil
Prior art keywords
methods
aryl
stereoisomerically enriched
preparing
alkenyl
Prior art date
Application number
BRPI0417046-6A
Other languages
English (en)
Inventor
Shanghui Hu
Carlos Alberto Martinez
Junhua Tao
Daniel Rida Yazbeck
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0417046A publication Critical patent/BRPI0417046A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/24Proline; Hydroxyproline; Histidine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

"MéTODOS PARA O PREPARO DE AMINAS ESTéREO-ISOMERICAMENTE ENRIQUECIDAS". A presente invenção relaciona-se a métodos de preparo de um composto estereoisomericamente enriquecido de fórmula (I) , onde R¬ 6¬ é hidrogênio, compreendendo tratar um composto de fórmula (I) , onde R¬ 6¬ é escolhido a partir de alquila C~ 1~-C~ 10~/ alquenila C~ 2~-C~ 10~, alquenila C~ 2-C~ 10, - (CR¬ 7¬ R¬ 8¬)~ t~ (arila C~ 6~-C~ 14~), e(CR¬ 7¬R¬ 8¬)~ t~ (arila C~ 6~-C~14~), e -(CR¬ 7¬R¬ 8¬)~ t~ (heterocíclico de 4-10 membros), onde os referidos arila C~ 6~-C~ 14~ e heterocíclico de 4-10 membros são opcionalmente substituídos com pelo menos um substituinte escolhido entre halo, alquila C~ 1~-C~ 10~, -OR¬ 7¬, e -N(R¬ 7¬R¬ 8¬), com um biocatalisador em uma solução aquosa, um solvente orgânico, ou uma mistura de solventes orgãnicos e aquosos onde pelo menos um estereoisómero é seletivamente hidrolisado.
BRPI0417046-6A 2003-12-04 2004-11-22 métodos para o preparo de aminas estereoisomericamente enriquecidas BRPI0417046A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52714303P 2003-12-04 2003-12-04
PCT/IB2004/003812 WO2005054186A2 (en) 2003-12-04 2004-11-22 Methods for the preparation of stereoisomerically enriched amines

Publications (1)

Publication Number Publication Date
BRPI0417046A true BRPI0417046A (pt) 2007-02-06

Family

ID=34652482

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417046-6A BRPI0417046A (pt) 2003-12-04 2004-11-22 métodos para o preparo de aminas estereoisomericamente enriquecidas

Country Status (14)

Country Link
US (1) US20050192441A1 (pt)
EP (1) EP1737818A2 (pt)
JP (1) JP2007521801A (pt)
KR (1) KR20060100457A (pt)
CN (1) CN101068780A (pt)
AU (1) AU2004295187A1 (pt)
BR (1) BRPI0417046A (pt)
CA (1) CA2549289A1 (pt)
CO (1) CO5700727A2 (pt)
IL (1) IL175737A0 (pt)
NO (1) NO20062944L (pt)
RU (1) RU2006119470A (pt)
WO (1) WO2005054186A2 (pt)
ZA (1) ZA200604545B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5119923B2 (ja) * 2005-09-02 2013-01-16 宇部興産株式会社 光学活性(S又はR)−α−ヒドロキシ酸及び光学活性(R又はS)−α−ヒドロキシ酸エステルの製造方法
CN101284797B (zh) * 2008-06-11 2010-08-11 常州恩滋生物科技有限公司 N-保护的烯丙基甘氨酸酯的拆分方法
JP2012512415A (ja) * 2008-12-17 2012-05-31 ザ ルブリゾル コーポレイション 機能性流体用光学活性マーカー
CN103797124B (zh) * 2011-07-20 2018-05-22 赢创德固赛有限公司 伯醇的氧化和胺化

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5644028A (en) * 1992-05-13 1997-07-01 Japan Energy Corporation Process for producing peptide derivatives and salts therefor
CA2179935C (en) * 1995-06-30 2010-09-07 Ryohei Kato Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US6222043B1 (en) * 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
CN1213400A (zh) * 1996-03-13 1999-04-07 隆萨股份公司 N-保护d-脯氨酸衍生物的制备方法
CZ213199A3 (cs) * 1996-12-16 1999-11-17 Lonza Ag Mikroorganismy, enzymy a způsob výroby derivátů D-prolinu
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
EP1737818A2 (en) 2007-01-03
NO20062944L (no) 2006-09-04
CO5700727A2 (es) 2006-11-30
WO2005054186A3 (en) 2007-04-19
KR20060100457A (ko) 2006-09-20
CA2549289A1 (en) 2005-06-16
IL175737A0 (en) 2006-09-05
AU2004295187A1 (en) 2005-06-16
JP2007521801A (ja) 2007-08-09
ZA200604545B (en) 2007-10-31
US20050192441A1 (en) 2005-09-01
WO2005054186A2 (en) 2005-06-16
RU2006119470A (ru) 2007-12-20
CN101068780A (zh) 2007-11-07

Similar Documents

Publication Publication Date Title
BRPI0613403A2 (pt) tetrahidrobenzodiazepinas aril- e heteroarila-substituÍdas e uso das mesmas para bloquear a recaptaÇço de norepinefrina, dopamina e serotonina
BR0114494A (pt) Composição para tratar um substrato, e, métodos para fabricar uma composição para o tratamento de um substrato, e para tratar um substrato
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BRPI0506719A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
CO6140059A2 (es) Derivados de imidazol-pirimidina para el tratamiento de enfermedades relacionadas con la glicogeno sintasa quinasa (gsk3)
BRPI0510940A (pt) 1-aza-biciclo-3.1.1-nonanos
WO2008081096A3 (fr) Derives quinolinyliques, leur procede de preparation. les compositions pharmaceutiques qui les contiennent et leur utilisation comme agents hypoglycemiants et hypoli pemiants
BRPI0415070B8 (pt) derivados de dibenzo-azepina e benzo-diazepina substituídos úteis, seu uso e seu processo de preparação, e medicamento
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
BRPI0811200A8 (pt) Tetra-hidrobenzapinas arilóxi- e heteroarilóxi-substituídas e uso das mesmas para bloquear percepção de norepinefrina, dopamina, e serotonina
BRPI0811204A8 (pt) Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
BRPI0509095A (pt) método para produzir um composto aminofenol
SE0401969D0 (sv) Piperidine derivatives
BRPI0516994A (pt) processo para preparação de pirazóis
BRPI0417046A (pt) métodos para o preparo de aminas estereoisomericamente enriquecidas
ECSP056103A (es) Tratamiento de pigmentos de alto rendimiento
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
BRPI0508563A (pt) derivados de carbamato de 2h- ou 3h-benzo[e]indazol-1-ila, seu preparo e sua aplicação em terapêutica
RS54736B1 (sr) Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina
BR0308252A (pt) Composição de revestimento compreendendo um ligante acetal-funcional
BRPI0512632A (pt) processo para a preparação de biarildifosfinas assimetricamente substituìdas
BR0112064A (pt) Processo para a preparação de derivados da quinolina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 4A., 5A., 6A. E 7A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.